A large number of previous studies in humans have suggested a possible correlation between genetic polymorphisms of CAT and susceptibility to cancers, such as prostate cancer [10–14], breast cancer [15], and hepatocellular carcinoma [16–19]. This evidence concerns the gene CAT and prostate carcinoma.